Skip to main content
Clinical Trials/JPRN-UMIN000010552
JPRN-UMIN000010552Completed未知

Study on efficacy and safety of levetiracetam administration by nasogastric tube in patients with convulsive status epilepticus - Levetiracetam administration by nasogastric tube in convulsive status epilepticus

Department of Emergency and Critical Care Medicine, Wakayama Medical University0 sites20 target enrollmentStarted: April 21, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18years-old to 90years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patinets with non-convulsive status epilepticus Patients required administration of sedative with anticonvulsive effect Systolic blood pressure <60mmHg, >=220mmHg Heart rate <40/min, >=150/min Respiration rate <5/min, >=40/min SpO2 <89% Unstable state of airway Acute coronary syndrome Active gastrointestinal bleeding Patients required intermittent hemodialysis or continuous renal replacement therapy Levetiracetam allergy Patients considered as inappropriate to participate in this study by attending physicians

Investigators

Sponsor
Department of Emergency and Critical Care Medicine, Wakayama Medical University

Similar Trials